Abstract 378: Predictive and pharmacodynamic biomarkers of the androgen receptor in circulating tumor cells
Jamie M. Sperger(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), Erika Héninger(University of Wisconsin Carbone Cancer Center), Sacha Horn(University of Wisconsin–Madison), Chorom Pak(Unknown), Lindsay N. Strotman(University of Wisconsin–Madison), David J. Beebe(University of Wisconsin–Madison), Benjamin P. Casavant(University of Wisconsin–Madison), Scott Berry(Queen's University)
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
|New England Journal of Medicine|2013|980
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818